74 related articles for article (PubMed ID: 16051634)
21. Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells.
Pratt MA; White D; Kushwaha N; Tibbo E; Niu MY
Apoptosis; 2007 Apr; 12(4):657-69. PubMed ID: 17252199
[TBL] [Abstract][Full Text] [Related]
22. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells.
Catalano MG; Costantino L; Frairia R; Boccuzzi G; Fortunati N
Horm Metab Res; 2007 Apr; 39(4):288-94. PubMed ID: 17447168
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways.
Chen XN; Zhu H; Meng QY; Zhou JN
Brain Res; 2008 Aug; 1223():1-10. PubMed ID: 18597742
[TBL] [Abstract][Full Text] [Related]
24. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
Zheng ZY; Lin VC
Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-dependent responses of the mammary fat pad in prepubertal dairy heifers.
Meyer MJ; Capuco AV; Boisclair YR; Van Amburgh ME
J Endocrinol; 2006 Sep; 190(3):819-27. PubMed ID: 17003282
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional profiles of progestogen effects in the postmenopausal breast.
Wood CE; Register TC; Cline JM
Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
[TBL] [Abstract][Full Text] [Related]
27. COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.
Le Dily F; Métivier R; Guéguen MM; Le Péron C; Flouriot G; Tas P; Pakdel F
Breast Cancer Res Treat; 2008 Jul; 110(1):69-83. PubMed ID: 17674191
[TBL] [Abstract][Full Text] [Related]
28. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
Zhou CH; Peng XD; Wu J; Zhang P; Zhao ZR; Wei DP; Zhang CJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):373-7. PubMed ID: 18575318
[TBL] [Abstract][Full Text] [Related]
30. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
31. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
[TBL] [Abstract][Full Text] [Related]
32. hTERT regulation by NF-κB and c-myc in irradiated HER2-positive breast cancer cells.
Papanikolaou V; Athanassiou E; Dubos S; Dimou I; Papathanasiou I; Kitsiou-Tzeli S; Kappas C; Tsezou A
Int J Radiat Biol; 2011 Jun; 87(6):609-21. PubMed ID: 21627565
[TBL] [Abstract][Full Text] [Related]
33. Estrogen regulation of thrombospondin-1 in human breast cancer cells.
Hyder SM; Liang Y; Wu J
Int J Cancer; 2009 Sep; 125(5):1045-53. PubMed ID: 19391135
[TBL] [Abstract][Full Text] [Related]
34. Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation.
Gérard C; Blacher S; Communal L; Courtin A; Tskitishvili E; Mestdagt M; Munaut C; Noel A; Gompel A; Péqueux C; Foidart JM
J Endocrinol; 2015 Jan; 224(1):85-95. PubMed ID: 25359896
[TBL] [Abstract][Full Text] [Related]
35. 17-beta-estradiol activates maxi-K channels through a non-genomic pathway in human breast cancer cells.
Coiret G; Matifat F; Hague F; Ouadid-Ahidouch H
FEBS Lett; 2005 Jun; 579(14):2995-3000. PubMed ID: 15893312
[TBL] [Abstract][Full Text] [Related]
36. Onset of direct 17-beta estradiol effects on proliferation and c-fos expression during oncogenesis of endometrial glandular epithelial cells.
Nemos C; Delage-Mourroux R; Jouvenot M; Adami P
Exp Cell Res; 2004 Jun; 296(2):109-22. PubMed ID: 15149842
[TBL] [Abstract][Full Text] [Related]
37. Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity.
Gadd SL; Hobbs G; Miller MR
Toxicol Sci; 2002 Apr; 66(2):233-43. PubMed ID: 11896290
[TBL] [Abstract][Full Text] [Related]
38. Identification of downstream targets of estrogen and c-myc in breast cancer cells.
Musgrove EA; Sergio CM; Anderson LR; Inman CK; McNeil CM; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Sutherland RL
Adv Exp Med Biol; 2008; 617():445-51. PubMed ID: 18497068
[TBL] [Abstract][Full Text] [Related]
39. Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells.
Lecomte S; Chalmel F; Ferriere F; Percevault F; Plu N; Saligaut C; Surel C; Lelong M; Efstathiou T; Pakdel F
Cell Commun Signal; 2017 Jun; 15(1):26. PubMed ID: 28666461
[TBL] [Abstract][Full Text] [Related]
40. Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer.
Wu X; Chen F; Sahin A; Albarracin C; Pei Z; Zou X; Singh B; Xu R; Daniels G; Li Y; Wei J; Blake M; Schneider RJ; Cowin P; Lee P
Breast Cancer Res Treat; 2011 Jul; 128(2):391-400. PubMed ID: 20814820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
